Wednesday, April 20, 2016

Ithaca’s Anti-Heroin Plan: Open a Site to Shoot Heroin

Photo
Officer Dana Haff and other law enforcement personnel removing drugs found after a raid at a home in Ithaca, N.Y., this month. CreditHeather Ainsworth for The New York Times
ITHACA, N.Y. — Even Svante L. Myrick, the mayor of this city, thought the proposal sounded a little crazy, though it was put forth by a committee he had appointed. The plan called for establishing a site where people could legally shoot heroin — something that does not exist anywhere in the United States.
“Heroin is bad, and injecting heroin is bad, so how could supervised heroin injection be a good thing?” Mr. Myrick, a Democrat, said.
But he also knew he had to do something drastic to confront the scourge of heroin in his city in central New York. So he was willing to take a chance and embrace the radical notion, knowing well that it would provoke a backlash.
And it has.
Ever since Mr. Myrick, 29, unveiled a plan last month for what he called a “supervised injection facility,” critics have pounced on it as a harebrained idea that would just enable more drug abuse. A Republican state legislator, Tom O’Mara, called it “preposterous” and “asinine,” and a Cornell law professor, William A. Jacobson, said it would be a “government-run heroin shooting gallery.”
Photo
Svante L. Myrick, the mayor of Ithaca, said his father’s battle with crack cocaine helped inspire him to confront the city’s heroin problem. CreditHeather Ainsworth for The New York Times
But others, including workers on the front lines of the heroin epidemic and some law enforcement officials, view the proposal as an important tool in the battle against addiction and overdoses, a way to keep users alive long enough to connect them to treatment. In the plan, users would be under medical supervision and could inject only a small amount of heroin.
full article

The Supreme Court Passes Up a Chance to Ban a Terrible Sentence


Photo
The United States Supreme Court building.Credit J. Scott Applewhite/Associated Press
It is pretty hard to make a straight-faced case in support of a mandatory sentence of life without parole for simple possession of marijuana.
Unfortunately, such sentences will continue to be legal for now, following the Supreme Court’s refusal on Monday to hear the appeal of Lee Carroll Brooker, a 75-year-old disabled veteran currently serving a mandatory life without parole sentence in Alabama. His crime? Growing about three dozen marijuana plantsbehind his son’s house in Dothan. He said the plants were for his own medicinal use only — he suffers from multiple chronic ailments — and prosecutors did not dispute that.
Remarkably, they didn’t have to. Alabama, like three other states, mandates a life without parole sentence for simple possession of small amounts of marijuana by people with certain prior felony convictions — and Mr. Brooker had been convicted of a string of robberies twenty years earlier in Florida, crimes for which he served 10 years in prison. In such a case, the law doesn’t require prosecutors to prove any intent to sell the drug.
In Mississippi, 30 grams — barely one ounce — is enough to send someone to prison for the rest of his or her life, with no chance of release. Alabama’s cutoff is slightly higher, at one kilogram, or 2.2 pounds, but that makes no more sense, and was no help to Mr. Brooker, whose plants weighed in at 2.8 pounds, including unusable parts like stalks and leaves.
Mr. Brooker’s sentencing judge said he would have imposed a shorter sentence if he could have, and Roy Moore, the state’s chief justice, called Mr. Brooker’s sentence “excessive and unjustified.” (It’s worth noting that while the sentence was mandatory, the prosecutor was not required to bring the precise charges that triggered it. Prosecutorial discretion here, as in most cases, is a central factor in determining what punishment defendants face.)
complete article

Sunday, April 17, 2016

No link found between psychedelics and psychosis


NATURE | NEWS
In large US survey, users of LSD and similar drugs were no more likely to have mental-health conditions than other respondents.
 Corrected:

Article tools

Rights & Permissions

Getty Images/MattLyon
An image inspired by the reported experiences of psychedelic drug users. Anecdotal evidence of 'acid casualties' — users who develop chronic psychoses —is not supported by data from large populations, researchers say.
Data from population surveys in the United States challenge public fears that psychedelic drugs such as LSD can lead to psychosis and other mental-health conditions and to increased risk of suicide, two studies have found1, 2.
In the first study, clinical psychologists Pål-Ørjan Johansen of EmmaSofia, a non-profit advocacy group based in Oslo, and Teri Suzanne Krebs of the Norwegian University of Science and Technology in Trondheim, scoured data from the US National Survey on Drug Use and Health (NSDUH), an annual random sample of the general population, and analysed answers from more than 135,000 people who took part in surveys from 2008 to 2011.
Of those, 14% described themselves as having used at any point in their lives any of the three ‘classic’ psychedelics: LSD, psilocybin (the active ingredient in so-called magic mushrooms) and mescaline (found in the peyote and San Pedro cacti). The researchers found that individuals in this group were not at increased risk of developing 11 indicators of mental-health problems such as schizophrenia, psychosis, depression, anxiety disorders and suicide attempts. Their paper appears in the March issue of the Journal of Psychopharmacology1.
The findings are likely to raise eyebrows. Fears that psychedelics can lead to psychosis date to the 1960s, with widespread reports of “acid casualties” in the mainstream news. But Krebs says that because psychotic disorders are relatively prevalent, affecting about one in 50 people, correlations can often be mistaken for causations. “Psychedelics are psychologically intense, and many people will blame anything that happens for the rest of their lives on a psychedelic experience.”
...
The second of the new two studies, also published in the Journal of Psychopharmacology2, looked at 190,000 NSDUH respondents from 2008 to 2012. It also found that the classic psychedelics were not associated with adverse mental-health outcomes. In addition, it found that people who had used LSD and psilocybin had lower lifetime rates of suicidal thoughts and attempts.

Saturday, April 16, 2016

Brain scans reveal how LSD affects consciousness

Drug researcher David Nutt discusses brain-imaging studies with hallucinogens.11 April 2016

Article tools


Imperial College London
Under the influence of LSD, the brain's visual cortex has increased connectivity with other brain regions (right) than when imaged under placebo (left).
Researchers have published the first images showing the effects of LSD on the human brain, as part of a series of studies that are examining how the drug causes its characteristic hallucinogenic effects1.

Significance

Lysergic acid diethylamide (LSD), the prototypical “psychedelic,” may be unique among psychoactive substances. In the decades that followed its discovery, the magnitude of its effect on science, the arts, and society was unprecedented. LSD produces profound, sometimes life-changing experiences in microgram doses, making it a particularly powerful scientific tool. Here we sought to examine its effects on brain activity, using cutting-edge and complementary neuroimaging techniques in the first modern neuroimaging study of LSD. Results revealed marked changes in brain blood flow, electrical activity, and network communication patterns that correlated strongly with the drug’s hallucinatory and other consciousness-altering properties. These results have implications for the neurobiology of consciousness and for potential applications of LSD in psychological research.
_____________________________
Lysergic acid diethylamide (LSD) is the prototypical psychedelic drug, but its effects on the human brain have never been studied before with modern neuroimaging. 
...

Lysergic acid diethylamide (LSD) is a potent serotonergic hallucinogen or “psychedelic” that alters consciousness in a profound and characteristic way. First synthesized in 1938, its extraordinary psychological properties were not discovered until 1943 (1). LSD would go on to have a major effect on psychology and psychiatry in the 1950s and 1960s; however, increasing recreational use and its influence on youth culture provoked the drug’s being made illegal in the late 1960s. As a consequence, human research with LSD has been on pause for half a century. However, inspired by a revival of research with other psychedelics, such as psilocybin and ayahuasca, a small number of new reports on the psychological effects of LSD have recently been published (2⇓⇓⇓–6).
LSD has a high affinity for a range of different neurotransmitter receptors, but its characteristic psychological effects are thought to be mediated by serotonin 2A receptor (5-HT2AR) agonism (7).
...
Consistent with a prior hypothesis (17), these studies suggest that an “entropic” effect on cortical activity is a key characteristic of the psychedelic state. 
...
resting state functional connectivity



Discussion

The present findings offer a comprehensive new perspective on the changes in brain activity characterizing the LSD state, enabling us to make confident new inferences about its functional neuroanatomy. Principal findings include increased visual cortex CBF, RSFC, and decreased alpha power, predicting the magnitude of visual hallucinations; and decreased DMN integrity, PH-RSC RSFC, and delta and alpha power (e.g., in the PCC), correlating with profound changes in consciousness, typified by ego-dissolution. More broadly, the results reinforce the view that resting state ASL, BOLD FC, and MEG measures can be used to inform on the neural correlates of the psychedelic state (9, 16). Importantly, strong relationships were found between the different imaging measures, particularly between changes in BOLD RSFC (e.g., network “disintegration” and “desegregation”) and decreases in oscillatory power, enabling us to make firmer inferences about their functional meaning.
The present study sheds new light on the relationship between changes in spontaneous brain activity and psychedelic-induced visual hallucinations. Strong relationships were observed between increased V1 RSFC and decreased alpha power, as well as ratings of both simple and complex visual hallucinations. The latter result is consistent with previous findings with psilocybin (29). Importantly, a very strong relationship was also observed between increased V1 RSFC and decreased alpha power in occipital sensors, suggesting that as well as being commonly related to visual hallucinations, these physiological effects are closely interrelated. The increase in V1 RSFC under LSD is a particularly novel and striking finding and suggests that a far greater proportion of the brain contributes to visual processing in the LSD state than under normal conditions. This expansion of V1 RSFC may explain how normally discreet psychological functions (e.g., emotion, cognition, and indeed the other primary senses) can more readily “color” visual experience in the psychedelic state.
Biologically informed modeling has suggested that instability within the primary visual cortex may facilitate the emergence of geometric hallucinations via self-organized patterns of neural excitation (30), and eyes-closed fMRI recordings during ayahuasca hallucinations suggest the visual cortex behaves “as if” there is external input when there is none (31) (see also ref. 29). The present findings of increased visual cortex CBF, expanded V1 RSFC, and decreased alpha power may be seen as consistent with the notion of “seeing with eyes-shut” under psychedelics, because they are all properties normally associated with visual stimulation (32, 33). Cortical alpha has been hypothesized to serve a general inhibitory function, filtering out “stimulus-irrelevant” information (34). Thus, reduced alpha power (9, 29, 35) could have disinhibitory consequences, facilitating the release of anarchic patterns of excitation that manifest spontaneously and experientially as visual hallucinations. This hypothesis is leant (indirect) support by two prior studies that found reduced spontaneous visual cortex alpha power under psilocybin alongside reduced evoked visual responses (9, 29). Further work, using higher-resolution brain imaging, machine learning techniques, dynamic measures of functional and effective connectivity, and improved “capture” of visual hallucinations (e.g., via button press or experience sampling), may help to develop this appealing model (e.g., see ref. 36).
The present data also inform on another fundamental question; namely, how do psychedelics alter brain function to (so profoundly) alter consciousness? Interestingly, although the effects of LSD on the visual system were pronounced, they did not significantly correlate with its more fundamental effects on consciousness. Instead, a specific relationship was found between DMN disintegration and ego-dissolution, supporting prior findings with psilocybin (17). Also consistent with previous psilocybin research (9), a significant relationship was found between decreased PCC alpha power and ego-dissolution. Moreover, an especially strong relationship was found between PH-RSC decoupling and ego-dissolution (see also ref. 10). Thus, in the same way the neurobiology of psychedelic-induced visual hallucinations can inform on the neurobiology of visual processing, so the neurobiology of psychedelic-induced ego-dissolution can inform on the neurobiology of the “self” or “ego” (37), and the present results extend our understanding in this regard, implying that the preservation of DMN integrity, PH-RSC communication, and regular oscillatory rhythms within the PCC may be important for the maintenance of one’s sense of self or ego.
Linking these results to pathology, an especially strong relationship was found between PH-RSC decoupling and the “altered meaning” factor on the ASC. Interestingly, altered activity within the PH-RSC circuit under psilocybin has previously been found to correlate with the spiritual experience and insightfulness dimensions of the 11-factor ASC (10), and altered RSC/PCC activity has been found to correlate with ego-dissolution (9), suggesting modulation of this particular circuit may be an important feature of especially profound psychedelic experiences. The altered meaning factor of the ASC is composed of items such as “some unimportant things acquired a special meaning” and “things in my surroundings had a new or alien meaning” that are phenomenologically resonant with the notion of “aberrant salience” in schizophrenia research (38). Impaired reality testing as a corollary of impaired ego functioning may explain an association between ego-dissolution and altered meaning. Similarities between aspects of psychosis and the psychedelic state have long been debated, and one of the most influential hypotheses on the neurobiology of schizophrenia proposes a functional disconnect between certain brain structures in the disorder (39). In this context, it is intriguing to consider whether the PH-RSC circuit is involved in certain psychosis-related experiences (e.g., refs. 40 and41). More specifically, it would be interesting to examine the integrity of the PH-RSC connection in cases of endogenous psychoses in which phenomena such as altered meaning, ego-dissolution, and/or impaired reality-testing are observed. To our knowledge, these specific phenomena have never been formally investigated in imaging studies involving patients exhibiting endogenous psychoses, but studies on early psychosis and the at-risk mental state may be informative in this regard (e.g., ref. 40).
When the present results are considered in relation to previous human neuroimaging studies with psychedelics, some general principles emerge. It seems increasingly evident that psychedelics reduce the stability and integrity of well-established brain networks (e.g., ref. 16) and simultaneously reduce the degree of separateness or segregation between them (e.g., ref. 42); that is, they induce network disintegration and desegregation. Importantly, these effects are consistent with the more general principle that cortical brain activity becomes more “entropic” under psychedelics (17). Furthermore, with the benefit of the present study’s multimodal imaging design, we can extend on these generic insights to postulate some more specific physiological properties of the psychedelic state and how these relate to some of its key psychological properties; namely, expanded V1 RSFC relates to the magnitude of visual hallucinations and decoupling of the PH-RSC circuit relates to the level of ego-dissolution, and perhaps also the profundity of a psychedelic experience more generally (also see refs. 9 and 10 in this regard).
Before concluding, we should highlight some general limitations of the present study and address a discrepant finding in the field. Regarding limitations, a fully randomized, double-blind design is often considered the gold standard; however, experimental blinding is known to be ineffective in studies with conspicuous interventions. Thus, a single-blind, balanced-order design with an inert placebo (offering the simplest and “cleanest” possible control condition) was considered an effective compromise. Also, although the multimodal design of this study was an advantage, the experimental protocol was demanding for participants, and the different scan types (ASL, BOLD, and MEG) occurred separately in time. Simultaneous EEG-fMRI may therefore offer some advantageous in this regard. Another general limitation of imaging studies involving potent psychoactive drugs, is the issue of between-condition differences in head motion and related artifacts. In this study, we opted to use the most rigorous motion-correction strategies available (SI Appendix), despite motion levels being no higher than those seen in previous studies by our group (16). Regarding the discrepant finding, a previous psilocybin ASL study of ours revealed decreased CBF postpsilocybin (i.v.) during eyes-open rest (16), whereas the present i.v. LSD study found increased CBF localized to the visual cortex with eyes-closed rest. One must be cautious of proxy measures of neural activity (that lack temporal resolution), such as CBF or glucose metabolism, lest the relationship between these measures, and the underlying neural activity they are assumed to index, be confounded by extraneous factors, such as a direct vascular action of the drug (43). For this reason, more direct measures of neural activity (e.g., EEG and MEG) and/or more dynamic fMRI measures (e.g., RSFC) should be considered more reliable indices of the functional brain effects of psychedelics, and it is notable in this regard that our previous MEG (9) and RSFC (16, 19, 42) findings with psilocybin are highly consistent with those observed here with LSD. Thus, rather than speculate on the above-mentioned discrepancy, it may be more progressive to highlight the advantages of EEG/MEG and dynamic fMRI and conclude that further work would be required to resolve discrepancies in the literature regarding the effects of psychedelics on metabolically related metrics that lack temporal resolution.
Finally, as evidence supporting the therapeutic potential of psychedelics mounts (6, 44⇓–46), so does our need to better understand how these drugs work on the brain. In many psychiatric disorders, the brain may be viewed as having become entrenched in pathology, such that core behaviors become automated and rigid. Consistent with their “entropic” effect on cortical activity (17), psychedelics may work to break down such disorders by dismantling the patterns of activity on which they rest. Future work is required to test this hypothesis and the others that have been presented here as part of a broader initiative to properly utilize these valuable scientific tools.


Friday, April 15, 2016

First paralysed person to be 'reanimated' offers neuroscience insights

NATURE | NEWS


Technique moves man's arm by decoding his thoughts and electrically stimulating his own muscles.

Article tools

Rights & Permissions
Ohio State University Wexner Medical Center/ Battelle
Ian Burkhart can make isolated finger movements and perform six different wrist and hand motions.
A quadriplegic man who has become the first person to be implanted with technology that sends signals from the brain to muscles — allowing him to regain some movement in his right arm hand and wrist — is providing novel insights about how the brain reacts to injury.
Two years ago, 24-year-old Ian Burkhart from Dublin, Ohio, had a microchip implanted in his brain, which facilitates the ‘reanimation’ of his right hand, wrist and fingers when he is wired up to equipment in the laboratory. Researchers led by Chad Bouton, currently at the Feinstein Institute for Medical Research in Manhasset, New York, have been studying Burkhart ever since, and publish their results on 13 April in Nature1.
Previous studies have suggested that after spinal-cord injuries, the brain undergoes 'reorganization' — a rewiring of its connections. But this new work suggests that the degree of reorganization occurring after such injuries may be less than previously assumed. “It gives us a lot of hope that there are perhaps not as many neural changes in the brain as we might have imagined after an injury like this, and we can bypass damaged areas of the spinal cord to regain movement," says Bouton. Previously, such a ‘neural bypass’ had been done in monkeys, and brain signals had been decoded in people and used to animate a robotic prosthetic arm, but this is the first time a person has had their own body part reanimated.
Burkhart — who is paralysed from the shoulders down but can move his shoulders and, to a small extent, his elbow — broke his neck after diving into waves during a beach holiday when he was 19. He later discovered that 25 minutes away from his home, researchers at Ohio State University in Columbus were developing the reanimation technology and decided to volunteer to have the microchip implanted.
Bouton and his colleagues took fMRI (functional magnetic resonance imaging) scans of Burkhart’s brain while he tried to mirror videos of hand movements. This identified a precise area of the motor cortex — the area of the brain that controls movement — linked to these movements. Surgery was then performed to implant a flexible chip that detects the pattern of electrical activity arising when Burkhart thinks about moving his hand, and relays it through a cable to a computer. Machine-learning algorithms then translate the signal into electrical messages, which are transmitted to a flexible sleeve that wraps around Burkhart’s right forearm and stimulates his muscles. “The first day we hooked it up I was able to get movement, and open and close my hand,” he says (see 'Ian talks about his new-found movement')

Ian talks about his new-found movement

Ohio State University Wexner Medical Center/ Battelle
How did you come to be paralysed?
I was on vacation with some friends. We were playing in the ocean and I dived into a wave that pushed me down into a sandbar and I broke my neck. The next day, I was told I’d be paralysed for the rest of my life. When you’re 19 years old, you think you’re invincible. But that quickly, all of your independence is taken away.
How did it feel the first time that you were plugged into the system?
The first day that we hooked it up I was able to get movement. It was something really small — being able to open and close my hand — but it was something that I hadn’t been able to do for about three years. So it reinstated a lot of hope that people with my kind of injury won’t just have to settle. Since then, we’ve been able to do a bunch of things that someone with my kind of injury should not be able to do.
Is it uncomfortable having an access port in your skull?
At first I would get headaches, and if I happened to bump the pedestal, that would really hurt. Now, I don’t really notice it’s there. It’s protected with a little cap, and it just feels like an extension of me.
What are your hopes for the future?
I’d really like to be able to take the system home with me. Not being able to walk doesn’t really matter to me because you can do a lot from a wheelchair, but if I was able to use my hands I would be a lot more independent than I currently am. But even if it’s something that I can never take home in my lifetime, I’m glad I’ve had the opportunity to take part in this study. I’ve had lots of fun with it. I know that I’ve done a lot of work to help other people as well.
 
Since then, he has been attending training sessions up to three times a week. As a result, Burkhart is currently able to make isolated finger movements and perform six different wrist and hand motions, enabling him to, among other things, pick up a glass of water, and even play a guitar-based video game.

Brain insights

The study provides insights into the brain’s ability to adapt to and exploit new situations. “It is interesting that, even some years after injury, when these circuits have presumably been sitting there not able to do much, that they still seem to be related to hand movements and haven’t been co-opted by something else,” says Andrew Jackson at Newcastle University, UK, who is separately developing a neural prosthesis to overcome spinal-cord injury.
Burkhart’s brain has also learned to coordinate the activity of his reanimated hand with muscles that he already has some control over. His ability to maintain grip while moving objects has gradually improved, and this has been associated with significant changes in his brain activity. The algorithms developed by Bouton’s team register and adapt to such changes in brain activity — effectively learning with the patient and fine-tuning his movements.
There are limitations on the freedom that the device affords Burkhart. The system can be used only in the laboratory and currently needs to be recalibrated at the start of each session. “This process is time-consuming and relatively technical,” says Jackson. “What we’d really like is neural interfaces that are stable from day-to-day and don’t require recalibration.”
Burkhart also can’t feel the objects that he’s manipulating; providing the brain with sensory feedback from his hand would enable him to adjust his grip strength more effectively, and to pick up objects that he can’t see.
It's not yet clear whether a neural bypass would work in people who don't have the type of residual elbow and shoulder movement that Burkhart does, or in people whose muscles are always contracted, a relatively common problem. “Being able to combine the recording of brain signals and produce the muscle contractions to make the hand do the correct things is a big step, but we’re still at a point where we’re talking about something that would benefit a small number of people,” says Elizabeth Tyler-Kabara, who directs the Neural Enhancement Laboratory at the University of Pittsburgh.